MVM
Medicxi Ventures Management Portfolio holdings
AUM
$835M
1-Year Est. Return
78.18%
This Fund
S&P 500
1 Year Est. Return
+78.18%
AUM
$744M
AUM Growth
+$317M
(+74%)
Holding
5
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$3.63B
| $484M | 65.03% |
19,963,157
|
|
||
2
Phathom Pharmaceuticals
PHAT
$1.07B
| $87.9M | 11.8% |
7,464,572
|
|
||
3
NewAmsterdam Pharma
NAMS
$3.53B
| $81.6M | 10.96% |
2,869,565
|
|
||
4
RAPT Therapeutics
RAPT
$1.67B
| $72.1M | 9.68% |
2,794,000
|
|
||
5
Aura Biosciences
AURA
$356M
| $18.8M | 2.52% |
3,039,892
|
|